Comet Therapeutics Raises $28.5 Million Series A Financing to Support Development of Treatments Built Around Its Novel CoEnzyme A Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2WSXZaa
via IFTTT